Home › Funds › Boxer Capital Management, LLC › INO

Boxer Capital Management, LLC position in INO

INOVIO PHARMACEUTICALS · Health Care

Boxer Capital Management, LLC reported holding 2,844,994 shares of INO (INOVIO PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$3.1M, representing 0.24% of its reported portfolio and ranking #48 among its reported holdings. Boxer Capital Management, LLC has disclosed INO holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)2.84M sh
Reported value held$3.13M
Portfolio Weight0.24%
First reportedQ3 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Boxer Capital Management, LLC's INO position evolved

Boxer Capital Management, LLC first disclosed a stake in INO in Q3 2025 at 2,300,000 shares (US$5.4M). Across 4 filings, Boxer Capital Management, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,844,994 shares valued at US$3.1M — an increase of 474,872 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2025 2.30M $5.38M New
Q4 2025 2.42M $4.21M Add
Q1 2026 2.37M $4.12M Reduce
Q2 2026 2.84M $3.13M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INO and 13F data

INO (INOVIO PHARMACEUTICALS) is a Health Care company. 26 other funds we track also report a position in INO. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INO

No other tracked fund reports a position in INO.

All INO fund holders →

FAQ

How long has Boxer Capital Management, LLC held INO?

Boxer Capital Management, LLC has disclosed INO holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Boxer Capital Management, LLC's current position in INO?

As of Q2 2026, Boxer Capital Management, LLC holds 2.84M shares of INO (INOVIO PHARMACEUTICALS), valued at $3.13M, representing 0.24% of its reported portfolio and ranking #48.

Has Boxer Capital Management, LLC been buying or selling INO?

In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC increased its position in INO.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.